Oncology Communications

Publishing Model:
ISSN:
ISSN: pending
Oncology Communications is a peer-reviewed journal dedicated to advancing knowledge across all aspects of cancer research and clinical oncology. The journal publishes high-quality original research articles, reviews, and perspectives that foster communication among basic scientists, clinicians, and translational researchers.
DOI Prefix: 10.62762/OC

Journal Metrics

-
Impact Factor
-
CiteScore

Recent Articles

Open Access | Letter | 29 January 2026
Revisiting The Dual Role of Radiotherapy in EGFR-mutant NSCLC: Implications for Therapeutic Combination Strategies
Oncology Communications | Volume 1, Issue 1: 5-7, 2025 | DOI: 10.62762/OC.2025.306213
Abstract
The article by Piffkó A et al. elucidates the double-edged sword role of radiotherapy in cancer treatment. Radiotherapy stimulates tumor cells to secrete amphiregulin (AREG), which in turn activates EGFR$^+$ tumor-associated mononuclear phagocytes (MNPs). This activation feeds back into the EGFR signaling pathway, impairing the anti-tumor functions of MNPs. Moreover, AREG upregulates the expression of the immune checkpoint protein CD47 in tumor cells, thereby enabling them to evade immune-mediated phagocytosis. These insights hold important implications for clinical trial design and for optimizing therapeutic strategies. More >
Open Access | Editorial | 03 November 2025
Editorial for Oncology Communications: Integrating Innovation for Transformative Cancer Care
Oncology Communications | Volume 1, Issue 1: 1-4, 2025 | DOI: 10.62762/OC.2025.363963
Abstract
This editorial mainly states the meaning of creating the Oncology Communications and highlights the importance and outlook of integrative medicine. We stress the importance of multidisciplinary, interdisciplinary, and cross-disciplinary collaboration, encouraging oncologists to work closely with experts from various fields, including basic medicine, mathematics, physics, sociology, artificial intelligence, and materials science. This collaboration aims to clarify the mechanisms of tumor development and progression, identify novel therapeutic targets, promote clinical translation, and ultimately benefit patients. More >

Journal Statistics

12
Authors
1
Countries / Regions
2
Articles
0
Citations
2025
Published Since
0
Special Issues
300
Article Views
154
Article Downloads
Oncology Communications
Oncology Communications
eISSN: pending
Crossref
Crossref
Member of Crossref
Visit Crossref →